Home > Cashflow Statement > INDSWIFT LABORATORIES

INDSWIFT LABORATORIES
Cashflow Statement

INDSWIFT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

INDSWIFT LABORATORIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹35 Cr₹195 Cr₹113 Cr₹13 Cr₹18 Cr
Adjustment ₹-40 Cr₹125 Cr₹133 Cr₹226 Cr₹179 Cr
Changes In working Capital ₹-20 Cr₹-483 Cr₹-51 Cr₹-88 Cr₹-62 Cr
Cash Flow after changes in Working Capital ₹-25 Cr₹-163 Cr₹195 Cr₹150 Cr₹135 Cr
Cash Flow from Operating Activities ₹-25 Cr₹-163 Cr₹195 Cr₹150 Cr₹135 Cr
Cash Flow from Investing Activities ₹-110 Cr₹-104 Cr₹-13 Cr₹4.77 Cr₹-10 Cr
Cash Flow from Financing Activities ₹69 Cr₹681 Cr₹-186 Cr₹-141 Cr₹-124 Cr
Net Cash Inflow / Outflow ₹-66 Cr₹413 Cr₹-4.41 Cr₹14 Cr₹1.03 Cr
Opening Cash & Cash Equivalents ₹494 Cr₹18 Cr₹21 Cr₹12 Cr₹11 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-0.58 Cr₹0.45 Cr₹1.13 Cr--
Closing Cash & Cash Equivalent ₹427 Cr₹432 Cr₹18 Cr₹26 Cr₹12 Cr

Compare Cashflow Statement of peers of INDSWIFT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDSWIFT LABORATORIES ₹1,074.7 Cr 21.4% 39.5% 11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


INDSWIFT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDSWIFT LABORATORIES

21.4%

39.5%

11.4%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses